share_log

Oppenheimer Maintains Outperform on Teladoc Health, Lowers Price Target to $26

Benzinga ·  Oct 25, 2023 09:45

Oppenheimer analyst Michael Wiederhorn maintains Teladoc Health (NYSE:TDOC) with a Outperform and lowers the price target from $35 to $26.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment